IP Library Granted Patent US 9,251,583
Granted Patent B2
US 9,251,583 · App. 14/202,357 · Granted Feb 2, 2016

Analysis, secure access to, and transmission of array images

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,251,583
App. No.
14/202,357
Granted
Feb 2, 2016
Kind
B2
Abstract

Systems and methods are provided the autocentering, autofocusing, acquiring, decoding, aligning, analyzing and exchanging among various parties, images, where the images are of arrays of signals associated with ligand-receptor interactions, and more particularly, ligand-receptor interactions where a multitude of receptors are associated with microparticles or microbeads. The beads are encoded to indicate the identity of the receptor attached, and therefore, an assay image and a decoding image are aligned to effect the decoding. The images or data extracted from such images can be exchanged between de-centralized assay locations and a centralized location where the data are analyzed to indicate assay results. Access to data can be restricted to authorized parties in possession of certain coding information, so as to preserve confidentiality.

Claims (19)

1. A method of conducting an assay and analyzing results therefrom at separate locations, comprising:

conducting an assay on a patient sample by contacting a uniquely encoded array of receptors with the patient sample and determining if the patient sample comprises any ligands that interact with the receptors by analyzing an assay image for optical signatures that are associated with receptor-ligand interactions,

recording the assay image in a first processor, and

decoding the array with a second processor at a location other than the location at which the assay is conducted, wherein the first and second processors communicate by way of a data network,

wherein the array is decoded by segmenting an image of the array, wherein information about the array geometry is known, said segmenting comprising creating a reference grid based on a brightfield image of the array such that each individual field of the grid includes a single object and the outer dimension of the grid corresponds to the dimensions of the array, and calculating an optical signal for each individual grid field, wherein the signal is characteristic of the object contained in said field.

2. The method of claim 1 , wherein the uniquely encoded array is an array of encoded beads, wherein different beads have different receptors associated therewith.

3. The array of claim 2 , wherein the encoding of the beads is with different colors.

4. The array of claim 1 , wherein the optical signatures from the receptors result from the association of a fluorescent entity with the ligand attached to the receptor.

5. The method of claim 1 , further comprising obtaining the patient sample, wherein the obtaining and conducting steps are conducted at separate locations.

6. The method of claim 1 , further including the step of providing the one or more images of the uniquely encoded array of receptors recorded before conducting the assay to the location at which the assay was conducted, to the patient, or to another location.

7. The method of claim 1 , further including the step of providing the one or more images of the uniquely encoded array of receptors recorded after conducting the assay to the location at which the assay was conducted, to the patient, or to another location.

8. The method of claim 1 , wherein the assay relates to patient genetic information or to information about certain proteins or antibodies in a patient.

9. The method of claim 1 , wherein the assay relates to the presence of tumor markers, markers associated with autoimmune disorders, blood-borne viruses, therapeutic drugs, genetic mutations associated with genetic diseases, polymorphisms, or other chromosomal abnormalities in the patient sample.

10. The method of claim 1 , wherein the assay is a multiplexed assay.

11. The method of claim 1 , further including the step of transmitting the assay image, one or more images of the uniquely encoded array of receptors, or both to a location where the images are archived.

12. The method of claim 1 , wherein the identity of the patient from whom the patient sample is obtained is available only to authorized parties.

13. The method of claim 11 , wherein all images are transmitted with an encryption key so that an image can be accessed only by an authorized party with access to the encryption key.

14. The method of claim 13 , wherein the encryption key is a pattern of the encoded array of receptors.

15. The method of claim 13 , wherein the encryption key is a bar code or other unique identifier code.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0033 →
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0111 →
RELEASE OF PATENT SECURITY INTERESTS Recorded Jul 2, 2020
From: CITIBANK, N.A.
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.; SIRONA GENONICS, INC.
Reel/Frame 053121/0935 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0135 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: ALTER DOMUS (US) LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0152 →
SECURITY AGREEMENT Recorded Jul 21, 2017
From: BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 043288/0785 →